Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Medicines Evaluation Board | Researchclopedia

Back to institutions

Medicines Evaluation Board

Utrechteducation

1,147

Works

56,509

Citations

101

h-index

Top Research Topics

Health Systems, Economic Evaluations, Quality of Life Pharmaceutical studies and practices Pharmaceutical Economics and Policy

Top Researchers

Jeroen J. Bax Leiden University

3,096 works244,399 citationsh-index: 189

Recent Research

Nonclinical safety testing of human pharmaceuticals in relation to clinical development

Jan Willem van der Laan

20260 citations

Biosimilars and Bioanalytical Methods

Pharmacovigilance and Adverse Drug Reactions

Statistical Methods in Clinical Trials

Biomedical Ethics and Regulation

Pharmaceutical industry and healthcare

Computational Drug Discovery Methods

Animal testing and alternatives

Pharmaceutical Practices and Patient Outcomes

Schizophrenia research and treatment

Arno W. Hoes University Medical Center Utrecht

690 works143,985 citationsh-index: 119

L.M. Bouter Amsterdam University Medical Centers

1,144 works124,735 citationsh-index: 158

Henrica C. W. de Vet Amsterdam University Medical Centers

755 works97,394 citationsh-index: 128

Cornelis J.�H. van de Velde Leiden University Medical Center

1,056 works76,813 citationsh-index: 119

309 works64,473 citationsh-index: 108

M4 common technical dossier

Jan Willem van der Laan

20260 citations

A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis

Stefan Verweij,Maarten J. Bijlsma,et al.

20260 citations

Reduced Genotoxicity Testing Is Possible for Noncoding Oligonucleotide-Based Therapeutics Containing Well-Characterized Modifications: A European Regulatory Perspective

Clara Stock,Britt Duijndam,et al.

20260 citations

Balancing benefit and risk in early Alzheimer's disease: the European Medicines Agency (EMA) assessment of lecanemab and donanemab

Lorenzo Guizzaro,Ewa Bałkowiec-Iskra,et al.

20260 citations

Tracing the path of non-industry-driven medicine development for rare diseases through regulatory interactions at the European Medicines Agency

Noa Rosenberg,Carla E M Hollak,et al.

20260 citations